Ebb Health, Inc. — SEC Form D Filing

Ebb Health, Inc. filed an SEC Form D on October 26, 2026, reporting $550K raised in Medical Devices.

Form D filing details

Filing
SEC Form D
Filing date
October 26, 2026
Amount reported
$550K
Round stage
Pre-seed due to raising $550,000 via a SAFE structure while operating pre-revenue.
Industry
Medical Devices
Website
https://ebbhealth.com

What the company does

Securities: Simple Agreement for Future Equity (SAFE). Revenue: No Revenues. Exemption: Rule 506(b). Incorporated: DELAWARE

Problem

Individuals struggle to seamlessly track and interpret their biological cycles and daily biometric health data to optimize personalized wellness.

Solution

Ebb Health builds an intuitive consumer digital health application that provides personalized biological insights and continuous wellness tracking.

Why now

The proliferation of consumer health sensors and accessible mobile AI tools enables automated, continuous health monitoring directly from a smartphone.

Verdict

This round cleared because the macro mandate to replace opioid prescriptions offered an effortless thematic tailwind for early-stage capital, not because the company proved a viable commercial distribution model. Investors treated the $550,000 check as a cheap option on patient-administered neuromodulation, betting that non-invasive hardware could bypass clinical friction. However, upside was immediately capped by historical pattern-matching against previous bioelectronic pain wearables, which routinely crashed on the rocks of poor patient adherence, brutal out-of-pocket consumer acquisition costs, and missing insurance reimbursement.

Source: SEC EDGAR Form D filing